Metrics Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Metrics plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Metrics Plus Today - Breaking & Trending Today

ATS 2024 Data Support Triple Therapy FF/UMEC/VI as Preferred Option for COPD

New data reveal that starting furoate/umeclidinium/vilanterol (FF/UMEC/VI) without delay not only significantly reduces exacerbations and health care costs but also enhances adherence and persistence for patients with chronic obstructive pulmonary disease (COPD) compared with other therapies. ....

United States , Stephen Noorduyn , International Conference , American Thoracic Society , Delayed Start , Metrics Plus ,

Does your ADHD medication increase your risk of glaucoma?

Does your ADHD medication increase your risk of glaucoma?
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

United States , Creativan Shutterstock , International Classification Of Diseases , Metrics Plus , International Classification , Clinical Modification ,

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain

1. The adoption of medical artificial intelligence (AI) technologies has increased exponentially over the past few years, both in terms of total number of claims and the development of new current procedural terminology (CPT) medical AI procedures. 2. Medical AI technology usage was shown to be largely restricted to metropolitan areas and/or those with an ....

United States , Drug Administration , American Association Of Medical Colleges , Us Department Of Agriculture , Rating Level , Metrics Plus , American Association , Medical Colleges , Artificial Intelligence , Current Procedural Terminology , Health Disparity , Insurance Claim , Machine Learning ,

Fixed Venetoclax Dosing May Not Be Feasible for All Patients With CLL

The retrospective cohort study evaluated data from 116 patients who received venetoclax as part of their first-line treatment and 145 patients in the relapsed/refractory setting.. ....

United States , Journal Of The National Comprehensive Cancer Network , Astrazeneca Pharmaceuticals , National Comprehensive Cancer , Metrics Plus , Southern United ,